Published: Jan 26, 2021, 03:55 IST | Updated: Jan 26, 2021, 03:55 IST
Pharmaceutical giant Astrazeneca is facing twin challenges in Europe, over efficacy and delivery. On Monday, German Daily reported government was unhappy with Astrazeneca's COVID vaccine. The report says that the jab was only 8% effective among people over-65 years.